Take Solutions Ltd Stock Price Today (NSE: TAKE)
Fundamental Score
Take Solutions Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Take Solutions Ltd share price today is ₹29.66, up +0.20% on NSE/BSE as of 17 June 2026. Take Solutions Ltd (TAKE) is a Small-cap company in the Healthcare Research, Analytics & Technology sector with a market capitalisation of ₹481.24 (Cr). The 52-week high for TAKE share price is ₹50.14 and the 52-week low is ₹8.33. At a P/E ratio of 120.61x, TAKE is currently trading above its industry average P/E of 45.95x. The company has a Return on Equity (ROE) of 644.12% and a debt-to-equity ratio of 0.00.
Take Solutions Ltd Share Price Chart — NSE/BSE Historical Performance
Take Solutions Ltd share price chart: -31.78% return over the past month. 52-week high ₹50.14, 52-week low ₹8.33.
Take Solutions Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹30.65 | ₹31.00 | ₹29.25 | ₹30.62 | 3.57L (Cr) | |
| ₹30.80 | ₹31.85 | ₹29.56 | ₹30.65 | 1.64L (Cr) | |
| ₹31.50 | ₹31.80 | ₹29.55 | ₹30.80 | 5.96L (Cr) | |
| ₹30.78 | ₹31.50 | ₹30.58 | ₹30.93 | 3.44L (Cr) | |
| ₹30.00 | ₹30.90 | ₹29.75 | ₹30.77 | 2.23L (Cr) | |
| ₹30.00 | ₹30.59 | ₹29.24 | ₹29.63 | 4.45L (Cr) | |
| ₹27.89 | ₹29.54 | ₹27.01 | ₹29.20 | 9.35L (Cr) | |
| ₹28.14 | ₹28.14 | ₹28.14 | ₹28.14 | 2.34L (Cr) | |
| ₹26.80 | ₹26.80 | ₹26.80 | ₹26.80 | 6.08L (Cr) | |
| ₹23.45 | ₹25.53 | ₹23.15 | ₹25.53 | 4.84L (Cr) |
Take Solutions Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹30.80 | ₹31.85 | ₹29.25 | ₹30.62 | -0.58% | |
| ₹40.56 | ₹42.69 | ₹23.15 | ₹30.80 | -24.06% | |
| ₹40.41 | ₹50.14 | ₹40.41 | ₹42.69 | +5.64% | |
| ₹40.11 | ₹43.00 | ₹32.68 | ₹39.62 | -1.22% | |
| ₹42.75 | ₹49.94 | ₹40.65 | ₹42.22 | -1.24% | |
| ₹40.48 | ₹45.00 | ₹34.80 | ₹41.54 | +2.62% | |
| ₹31.49 | ₹41.20 | ₹30.99 | ₹39.94 | +26.83% | |
| ₹21.40 | ₹32.10 | ₹21.10 | ₹30.99 | +44.81% | |
| ₹12.06 | ₹24.95 | ₹12.06 | ₹21.66 | +79.60% | |
| ₹10.03 | ₹11.69 | ₹10.03 | ₹11.49 | +14.56% | |
| ₹9.69 | ₹12.00 | ₹8.88 | ₹10.03 | +3.51% | |
| ₹9.38 | ₹11.98 | ₹9.10 | ₹9.89 | +5.44% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Take Solutions Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Take Solutions Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TAKE across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (644.12%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Robust Profit Growth (53.33%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (38.14% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (38.14% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹105.14 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Margin Pressure Concerns (-6.48%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 120.61x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Low Promoter Commitment (5.19%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Take Solutions Ltd vs Healthcare Research, Analytics & Technology Peers
Peer Comparison - Healthcare Research, Analytics & Technology
Compare Take Solutions Ltd with 8 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Take Solutions LtdTake Solutions ...Selected✓ TAKE • 532890 | 19.5/100 | ₹29.66₹30 | ₹481.24₹481.24 | 120.61Average 120.6 Average | 644.12%Excellent 644.12% Excellent | 11.24%Average 11.24% Average | 0.00Excellent 0.0 Excellent | 38.14%Excellent 38.14% Excellent | — — | 0.00% |
Syngene International LtdSyngene Interna... SYNGENE • 539268 | 41.6/100 | ₹460.40₹460 | ₹25985.68₹25985.68 | 55.50Average 55.5 Average | 10.53%Average 10.53% Average | 13.52%Average 13.52% Average | 0.12Excellent 0.1 Excellent | 5.71%Good 5.71% Good | 12.60%Good 12.60% Good | 0.19% |
Indegene LtdIndegene Ltd... INDGN • 544172 | 66.8/100 | ₹518.90₹519 | ₹12660.10₹12660.10 | 28.40Average 28.4 Average | 20.59%Excellent 20.59% Excellent | 24.80%Excellent 24.80% Excellent | 0.04Excellent 0.0 Excellent | 67.93%Excellent 67.93% Excellent | 34.59%Excellent 34.59% Excellent | 0.38% |
Suven Life Sciences LtdSuven Life Scie... SUVEN • 530239 | 6.5/100 | ₹267.15₹267 | ₹3927.58₹3927.58 | — — | -87.22%Poor -87.22% Poor | -86.96%Poor -86.96% Poor | 0.00Excellent 0.0 Excellent | -24.19%Poor -24.19% Poor | -12.00%Poor -12.00% Poor | 0.00% |
Vimta Labs LtdVimta Labs Ltd... VIMTALABS • 524394 | 65.8/100 | ₹456.70₹457 | ₹2716.50₹2716.50 | 36.39Average 36.4 Average | 19.43%Good 19.43% Good | 25.22%Excellent 25.22% Excellent | 0.02Excellent 0.0 Excellent | 58.03%Excellent 58.03% Excellent | 13.74%Good 13.74% Good | 0.16% |
Bilcare LtdBilcare Ltd... BI • 526853 | 6.9/100 | ₹62.20₹62 | ₹200.42₹200.42 | — — | -5.58%Poor -5.58% Poor | 1.10%Poor 1.10% Poor | 1.48Average 1.5 Average | 13.81%Good 13.81% Good | -15.48%Poor -15.48% Poor | 0.00% |
NOVELIX PHARMACEUTICALS LIMITENOVELIX PHARMAC... NOVELIX • 536565 | 40.6/100 | ₹57.14₹57 | ₹101.70₹101.70 | 104.85Average 104.8 Average | 0.64%Poor 0.64% Poor | 0.96%Poor 0.96% Poor | 0.00Excellent 0.0 Excellent | -2.33%Poor -2.33% Poor | 82.92%Excellent 82.92% Excellent | 0.00% |
Adeshwar Meditex LtdAdeshwar Medite... ADESHWAR • 543309 | 29.2/100 | ₹18.41₹18 | ₹25.54₹25.54 | 12.34Average 12.3 Average | 5.51%Poor 5.51% Poor | 8.27%Poor 8.27% Poor | 0.16Excellent 0.2 Excellent | -1.36%Poor -1.36% Poor | 8.33%Good 8.33% Good | 0.00% |
Vanta Bioscience LtdVanta Bioscienc... VANTABIO • 540729 | 7.2/100 | ₹24.45₹24 | ₹16.84₹16.84 | — — | -37.24%Poor -37.24% Poor | -11.58%Poor -11.58% Poor | 1.59Average 1.6 Average | — — | -32.27%Poor -32.27% Poor | 0.00% |
Top Healthcare Research, Analytics & Technology Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Syngene International Ltd share price25985.68 Cr
- Indegene Ltd share price12660.10 Cr
- Suven Life Sciences Ltd share price3927.58 Cr
- Vimta Labs Ltd share price2716.50 Cr
- Bilcare Ltd share price200.42 Cr
Take Solutions Ltd PE Ratio History
Historical price-to-earnings ratio for TAKE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹2.56 | ₹39.94 | 15.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Take Solutions Ltd Dividend History
Annual cash dividends paid by TAKE — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹0.04 Cr |
| FY 2024 | ₹0.07 Cr |
| FY 2023 | ₹0.07 Cr |
| FY 2022 | ₹0.01 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Take Solutions Ltd Quarterly Performance
Latest quarterly metrics for TAKE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
53.33%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
38.14%
Compounded annual net profit growth over 5 years
Take Solutions Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TAKE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Take Solutions Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Take Solutions Ltd (TAKE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Take Solutions Ltd
About TAKE (Take Solutions Ltd)
Take Solutions Ltd is a global technology company at the forefront of healthcare research, analytics, and technology. They are a dynamic force driving innovation across the healthc...are ecosystem. Specializing in intricate data analysis and technological solutions, TAKE empowers healthcare organizations to unlock valuable insights, optimize processes, and improve patient outcomes. Their commitment extends beyond simply offering services; it's about partnering with clients to navigate the ever-evolving landscape of healthcare, leveraging advanced analytics and cutting-edge technology to pave the way for meaningful advancements. Take Solutions works to transform data into actionable knowledge. TAKE provides an array of specialized services designed to address the unique challenges within the life sciences and healthcare sectors. Their expertise encompasses a broad spectrum, including clinical research support, advanced analytics for drug development, and solutions for regulatory compliance. They delve deep into healthcare data to identify trends, predict outcomes, and enhance the efficiency of research and development processes. This in-depth approach enables clients to make informed decisions, accelerate innovation, and ensure the highest standards of quality and safety in the development and delivery of healthcare products and services. TAKE's holistic approach leverages digital transformation and mobile solutions, improving the patient experience while generating payer insights. They are dedicated to pushing the boundaries of what's possible in healthcare, working with clients to create a healthier future for all. Their solutions are meticulously crafted to meet the specific needs of each client, ensuring that they receive customized support and achieve optimal results. With a focus on innovation, collaboration, and a commitment to excellence, TAKE Solutions Ltd is a driving force in the transformation of the healthcare industry.
Company Details
Key Leadership
Corporate Events
Latest News
TAKE Share Price: Frequently Asked Questions
What is the current share price of Take Solutions Ltd?
Take Solutions Ltd (TAKE) trades at ₹29.66 on NSE and BSE. Market cap ₹481.24 (Cr). Educational data only.
What is the P/E ratio of Take Solutions Ltd?
Take Solutions Ltd has a P/E of 120.61x vs industry average 45.95x.
What is the Bull Run score for Take Solutions Ltd?
Take Solutions Ltd has a Bull Run score of 19.5/100 based on 25+ financial parameters.
Does Take Solutions Ltd pay dividends?
Take Solutions Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Take Solutions Ltd?
Take Solutions Ltd has ROE of 644.12%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Take Solutions Ltd?
Take Solutions Ltd has debt-to-equity of 0.00.
Is Take Solutions Ltd a good investment?
Bull Run gives Take Solutions Ltd a score of 19.5/100. This is not investment advice — consult a SEBI-registered advisor.